# Minocycline After Successful Endovascular Thrombectomy Recanalization in Posterior Circulation Arterial Occlusion (ATTRACTION-MINOP)

> **NCT07594301** · PHASE2,PHASE3 · NOT_YET_RECRUITING · sponsor: **Xiang Luo** · enrollment: 234 (estimated)

## Conditions studied

- Acute Ischemic Stroke
- Endovascular Thrombectomy
- Minocycline
- Posterior Circulation
- Arterial Occlusion

## Interventions

- **DRUG:** Minocycline hydrochloride capsule
- **DRUG:** Placebo capsules of Minocycline hydrochloride capsules

## Key facts

- **NCT ID:** NCT07594301
- **Lead sponsor:** Xiang Luo
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-05
- **Primary completion:** 2028-12
- **Final completion:** 2028-12
- **Target enrollment:** 234 (ESTIMATED)
- **Last updated:** 2026-05-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07594301

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07594301, "Minocycline After Successful Endovascular Thrombectomy Recanalization in Posterior Circulation Arterial Occlusion (ATTRACTION-MINOP)". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT07594301. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*